Stocktoria
REVELATION BIOSCIENCES, INC. REVB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-10-08
REVELATION BIOSCIENCES, INC. statistics & valuation
Market cap$3.8M
P / B0.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -77.0% | -227.1% | -1.0% | -196.8% | -587.0% |
| Return on equity | -100.6% | -319.4% | -1.8% | -1029.0% | 153.2% |
| Current ratio | 5.41 | 3.43 | 2.18 | 1.22 | 0.89 |
Source: SEC EDGAR filings · CIK 0001810560 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.